Mode
Text Size
Log in / Sign up

Systematic review of Traditional Chinese Medicine for depression with unreported outcomes and safety data

Systematic review of Traditional Chinese Medicine for depression with unreported outcomes and safety…
Photo by 金 运 / Unsplash
Key Takeaway
Note that this systematic review lacks reported outcomes and safety data for TCM in depression.

This source is a systematic review focusing on the use of Traditional Chinese Medicine (TCM) for the treatment of depression. The interventions examined include botanical drug formulas, single medicinal botanical drugs, and their purified bioactive metabolites. The review scope encompasses these modalities but lacks specific details regarding the study population, sample size, setting, or comparator used in the underlying evidence.

The authors synthesize the available information but explicitly note that primary outcomes, secondary outcomes, and specific main results were not reported in the provided data. Consequently, no pooled effect sizes or quantitative efficacy data can be presented. Furthermore, safety information, including adverse events, serious adverse events, discontinuations, and tolerability, was not reported.

Due to the absence of reported data on outcomes and safety, the review does not provide definitive evidence on the clinical utility of these TCM interventions for depression. The limitations include the lack of reported population characteristics, sample sizes, and follow-up durations. Practice relevance cannot be determined from this source as the necessary outcome and safety metrics are missing. Clinicians should interpret these findings with caution given the incomplete data profile.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Depression is a major global health concern, characterized by profound mental and physical debilitation that severely impairs quality of life. The World Health Organization projects that it will become the second-leading cause of global disease burden by 2030, underscoring the urgent need for effective therapeutic strategies. However, the pathogenesis of depression remains incompletely elucidated, and first-line pharmacological treatments, such as selective serotonin reuptake inhibitors (SSRIs), are frequently limited by delayed clinical onset, suboptimal response rates, and notable adverse effects. In contrast, traditional Chinese medicine (TCM), with its holistic philosophy and potential for multi-target modulation, offers a promising complementary approach. This review systematically synthesizes contemporary research on TCM for depression, covering botanical drug formulas, single medicinal botanical drugs, and their purified bioactive metabolites. We critically evaluate the proposed mechanisms—spanning monoaminergic regulation, modulation of neurotrophic factors, anti-inflammatory activity, and interactions between the microbiota-gut-brain axis—and discuss the associated translational challenges and future research directions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.